STOP-ACEi Trial
@stopacei_trial
A clinical trial of ACE inhibitor and ARB withdrawal in patients with advanced CKD.
This project is funded by the EME Programme, an MRC and NIHR partnership.
ID: 4008274985
http://www.birmingham.ac.uk/stopacei 21-10-2015 08:54:56
206 Tweet
469 Followers
151 Following
Kazem Fallahzadeh, MD, MAS @askrenal We do not yet know whether stopping RAAS blockade in stage 4 or 5 CKD improves outcomes ... await STOP-ACEi Trial findings π This is one of the controversies raised during #KDIGOBPinCKD π¬π§ #Nephpearls #AskRenal ππΌ kdigo.org/wp-content/uplβ¦
Javi Rodriguez We do not yet know whether stopping RAAS blockade in stage 4 or 5 CKD improves outcomes ... await STOP-ACEi Trial findings π This was one of the controversies raised during KDIGO #KDIGOBPinCKD π¬π§ meeting #Nephpearls #NephJC ππΌ kdigo.org/wp-content/uplβ¦
Joseph Vassalotti, MD We do not yet know whether stopping RAAS blockade in stage 4 or 5 CKD improves outcomes ... await STOP-ACEi Trial findings π This was one of the controversies raised during KDIGO #KDIGOBPinCKD π¬π§ meeting #Nephpearls ππΌ kdigo.org/wp-content/uplβ¦
We do not yet know whether stopping RAAS blockade in stage 4 or 5 CKD improves outcomes ... await STOP-ACEi Trial findings π One of the controversies raised during #KDIGOBPinCKD π¬π§ meeting #Nephpearls ππΌ kdigo.org/wp-content/uplβ¦
More and more observations regarding benefits of RAASi in advanced CKD, awaiting the one RCT STOP-ACEi Trial for confirmation! JAMA Internal Medicine jamanetwork.com/journals/jamaiβ¦
Holly Kramer, MD, MPH Thanks for posting. Real struggle to disentangle clinician gestalt as a confounder when interpreting these outcomes youβd suspect? Everyone looking forward to results of STOP-ACEi Trial for RCT evidence.
LaurieTomlinson STOP-ACEi Trial I wish I had the answer but hopefully soon, probably next year
David Collister @petermagner2 Juan Carlos Q Velez Ayman Al Jurdi, MD FASN Nice one I am looking forward to the STOP-ACEi Trial as well
New paper out in JASN_News! We compared stopping versus continuing renin-angiotensin system inhibitors (ACEi or ARB) in patients with advanced CKD on the risks of death, MACE and KRT Juan Jesus Carrero LaurieTomlinson Catherine Clase jasn.asnjournals.org/content/early/β¦